Cabergoline Dosing for Deca and Trenbolone: How to Control Prolactin on 19-Nor Steroids in the UK

Cabergoline dosing on Deca and Trenbolone is the most frequently mismanaged ancillary protocol in UK bodybuilding because most users either skip it entirely, dose it blindly without bloodwork, or confuse prolactin symptoms with oestrogen symptoms and reach for more AI instead of the dopamine agonist they actually need. This guide explains why 19-nor steroids specifically elevate prolactin through a mechanism no other anabolic steroid class shares, gives you the exact cabergoline dosing protocol for every Nandrolone and Trenbolone dose range, covers when to start preventatively versus reactively, how long to continue after dropping the compound, and what a properly managed prolactin panel looks like on bloodwork. Available from Intex Pharma UK, Intex Pharma Cabergoline 0.25mg is the gold standard dopamine agonist for prolactin control on any 19-nor cycle.

Why 19-Nor Steroids Raise Prolactin: The Progesterone Receptor Mechanism

Nandrolone and Trenbolone are both 19-nortestosterone derivatives. The “19-nor” designation means they lack the carbon atom at the 19th position of the steroid backbone. This modification gives them exceptional anabolic potency, but it also enables them to bind to and activate the progesterone receptor with significant affinity. Progesterone receptor activation in the hypothalamus and pituitary gland stimulates prolactin secretion from lactotroph cells. Grattan and Bhatt (2019) in the Journal of Steroid Biochemistry and Molecular Biology reviewed the evidence on how progesterone stimulates prolactin secretion through both classical nuclear progesterone receptors (nPRs) and membrane progesterone receptors (mPRs), confirming that progestogenic activity at the pituitary level directly drives lactotroph stimulation and prolactin release.

This mechanism is entirely independent of oestrogen. Testosterone, Masteron, Anavar, Winstrol, Turinabol and every other non-19-nor anabolic steroid do not activate the progesterone receptor at bodybuilding doses and therefore do not produce clinically significant prolactin elevation. A user running 500mg of testosterone per week will not develop prolactin-related side effects from the testosterone itself. The moment Nandrolone or Trenbolone enters the stack, the prolactin equation changes fundamentally because a new hormonal pathway, progesterone receptor signalling, becomes active.

This is the single most important concept for understanding cabergoline dosing on Deca and Trenbolone: prolactin elevation from 19-nors is not an oestrogen problem and cannot be fixed with oestrogen management tools. Aromatase inhibitors do not lower prolactin. SERMs do not lower prolactin. Only dopamine agonists lower prolactin, and cabergoline is the most effective and best-tolerated dopamine agonist available. Colao et al. (2000) in the European Journal of Endocrinology established cabergoline as superior to bromocriptine for prolactin suppression, demonstrating that its long 63 to 69 hour elimination half-life allows once or twice weekly dosing while achieving more consistent prolactin control with fewer side effects.

Nandrolone vs Trenbolone: How Progestogenic Potency Differs

Both Nandrolone and Trenbolone are 19-nor compounds, but they are not equally progestogenic. Trenbolone binds to the progesterone receptor with considerably higher affinity than Nandrolone, producing more aggressive prolactin stimulation at equivalent doses. Practically, this means a user running 300mg of Trenbolone per week will experience greater prolactin elevation than a user running 300mg of Nandrolone per week, and the cabergoline dosing must reflect this difference.

Nandrolone also aromatises to a weak oestrogen (oestradiol at approximately 20% the rate of testosterone), which adds a secondary mechanism for nipple sensitivity and water retention that can complicate symptom interpretation. Trenbolone does not aromatise at all, meaning any breast tissue changes on Trenbolone are almost certainly prolactin-driven rather than oestrogen-driven. This distinction matters for diagnosis: if you are running Trenbolone without any aromatising compounds and develop nipple sensitivity or discharge, prolactin is the cause because there is no oestrogen pathway active. For a detailed diagnostic framework, see the guide on prolactin gynecomastia vs oestrogen gynecomastia.

Preventative vs Reactive Cabergoline Dosing

There are two valid approaches to cabergoline dosing on 19-nor cycles, and the correct choice depends on the compound, the dose, your personal prolactin sensitivity history and whether you have access to timely bloodwork.

Preventative dosing means starting cabergoline on the same day as your first 19-nor injection, before any prolactin elevation has occurred. This approach prevents prolactin from rising above baseline at all, which means you never experience the sexual dysfunction, mood disruption or breast tissue changes that elevated prolactin produces. The trade-off is additional drug exposure in users who may not have needed it; some men tolerate moderate-dose Nandrolone without significant prolactin elevation. Preventative dosing is recommended for all Trenbolone cycles regardless of dose, for Nandrolone above 400mg per week, and for any user who has experienced prolactin-related side effects on a previous 19-nor cycle.

Reactive dosing means monitoring with bloodwork and introducing cabergoline only when prolactin is confirmed elevated or symptoms appear. This minimises drug exposure but accepts the risk that symptoms may develop before intervention. Reactive dosing is reasonable for first-time 19-nor users running low to moderate Nandrolone (200 to 400mg/week) who want to establish their personal prolactin response before committing to an ancillary protocol. It requires bloodwork at week 4 to 6, which some users find impractical. For guidance on testing timing, assay selection and interpretation, see the full guide on how to read prolactin bloodwork on a steroid cycle.

Exact Cabergoline Dosing Protocols by Compound and Dose

Cabergoline’s 63 to 69 hour half-life means twice-weekly dosing maintains stable plasma concentrations without the peaks and troughs that shorter-acting dopamine agonists like bromocriptine produce. Each Intex Pharma Cabergoline tablet contains 0.25mg, which is the standard unit dose. The tables below give exact protocols by compound and weekly dose, with tablet counts calculated for the 0.25mg formulation.

The “Deca Dick” Problem: Why Skipping Cabergoline Ruins 19-Nor Cycles

“Deca dick” is bodybuilding shorthand for the erectile dysfunction and loss of libido that commonly occurs on Nandrolone cycles without prolactin management. The mechanism is straightforward: elevated prolactin suppresses dopamine signalling in the hypothalamus, and dopamine is the primary neurotransmitter responsible for sexual desire, erectile function and the ability to reach orgasm. When prolactin rises unchecked, dopamine activity drops, and the user experiences a progressive decline in libido, difficulty achieving or maintaining erections, and in severe cases, the complete inability to orgasm despite physical stimulation.

This is not a testosterone problem. The user’s serum testosterone may be supraphysiological from injecting 500mg per week, yet sexual function is impaired because the prolactin-dopamine axis, not the androgen axis, is the bottleneck. Adding more testosterone does not fix it. Adding AI does not fix it. The only intervention that directly addresses the cause is a dopamine agonist: cabergoline lowers prolactin by stimulating D2 receptors on lactotroph cells in the anterior pituitary, restoring the dopamine signal that prolactin was suppressing. For a complete explanation of how cabergoline restores libido through dopamine pathway stimulation, see the guide on cabergoline, dopamine and libido on 19-nor steroids.

Trenbolone produces the same sexual dysfunction through the same prolactin mechanism, though it is typically discussed less because Trenbolone users tend to be more experienced and often already include cabergoline in their ancillary protocol. Nevertheless, “Tren dick” is pharmacologically identical to “Deca dick”: elevated prolactin from progestogenic activity, suppressed dopamine, impaired sexual function. The treatment is the same: cabergoline at 0.25 to 0.5mg twice weekly.

When to Start and When to Stop Cabergoline by Ester

A critical mistake is stopping cabergoline on the same day as the last 19-nor injection. The compound does not leave the body instantly. Each ester has a different active life, and progestogenic activity persists until the parent compound has been fully metabolised and cleared. Stopping cabergoline prematurely allows prolactin to rebound while residual 19-nor compound is still stimulating progesterone receptors, producing a late-onset wave of prolactin symptoms that catches users off guard weeks after their “last pin.”

If you are transitioning from a 19-nor cycle into PCT, maintaining cabergoline through the clearance window and into the early PCT phase is essential. Elevated prolactin directly suppresses GnRH pulsatility at the hypothalamus, which delays LH and FSH recovery and prolongs the hypogonadal state. The PCT protocol with HCG and Clomid should include cabergoline continuation until prolactin bloodwork confirms normalisation. For the full mechanism, see the guide on cabergoline during PCT and how elevated prolactin delays HPTA recovery.

Signs of Elevated Prolactin vs Elevated Oestrogen: The Diagnostic Mistake That Costs Months

The symptoms of elevated prolactin and elevated oestrogen overlap significantly: nipple sensitivity, breast tissue changes, mood disruption, water retention and sexual dysfunction are common to both. On a 19-nor cycle where both oestrogen (from testosterone aromatisation) and prolactin (from progestogenic activity) can be elevated simultaneously, distinguishing the cause is critical because the treatments are different drugs acting on entirely different receptors.

The diagnostic key is nipple discharge. Clear or milky fluid expressed from the nipple (galactorrhoea) is prolactin-driven and does not occur from oestrogen elevation alone. Prolactin directly stimulates mammary gland secretory activity, which is its primary physiological function (lactation). If you are on a 19-nor compound and experience any degree of nipple discharge, the problem is prolactin and the treatment is cabergoline. Taking more Anastrozole or Letrozole will not resolve prolactin-driven discharge. Conversely, puffy or sore nipples without any discharge, especially on a testosterone-heavy stack without 19-nors, point toward oestrogen as the more likely cause. For the complete diagnostic framework with bloodwork confirmation, see the full guide on prolactin gynecomastia vs oestrogen gynecomastia.

Cost per Protocol: Intex Pharma Cabergoline 0.25mg at £31.00

At £6.20 per week for the standard Nandrolone protocol, cabergoline is one of the least expensive ancillaries in a 19-nor stack but arguably the most consequential. The cost of running a 16-week Deca cycle without cabergoline is not measured in pounds; it is measured in weeks of erectile dysfunction, destroyed libido, relationship strain and the frustration of side effects that could have been entirely prevented with two tablets per week. Run pre-cycle bloodwork to establish your baseline prolactin before starting any 19-nor compound.

Cabergoline Dosing for Deca and Trenbolone: Frequently Asked Questions